(1 - 6 von 7
)
Innoviva, GSK: EU Approves Label Update To Relvar Ellipta ...
www.finanznachrichten.de
Jonathan Sweeting, SVP and Head of Global Respiratory Franchise GSK, said: 'Patients with asthma can continue to experience symptoms despite being adequately controlled and these symptoms can ...
EU approves label update to Relvar Ellipta in patients with ...
www.pharmabiz.com
— Jonathan Sweeting, SVP and head of global respiratory franchise GSK, said: "Patients with asthma can continue to experience symptoms despite ... › News...
GSK's Nucala improves control of severe asthma - PharmaTimeswww.pharmatimes.com › news › g...
www.pharmatimes.com
... patients who are not well controlled by omalizumab,” noted Jonathan Sweeting, SVP and head, Global Respiratory Franchise at GSK.
GSK announces labelling update to Relvar Ellipta - Investis
otp.investis.com
— Jonathan Sweeting, SVP and Head of Global Respiratory Franchise GSK, said: Patients with asthma can continue to experience symptoms despite ... › rns_new
sortiert nach Relevanz / Datum